|
|
|
|
Virology analyses of simeprevir in Phase 2b and 3 studies
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Oliver Lenz,1 Thierry Verbinnen,1 Bart Fevery,1 Lotke Tambuyzer,1 Leen Vijgen,1 Monika Peeters,1 Annemie Buelens,1 Maria Beumont-Mauviel,1
Gaston Picchio,2 Sandra De Meyer1
1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2Janssen Research & Development, LLC, Titusville, NJ, USA
|
|
|
|
|
|
|